Improved insight into the mechanism of disease has been important to enable precision diabetes treatment for several of these disorders, e.g., sulphonylurea agents for the treatment in K-ATP neonatal diabetes (2–4), HNF4A-MODY, and HNF1A-MODY (5–7). Here, HNF1A is linked to diabetes mellitus.